脑部放疗，上午比下午敏感许多！, R/ h. L2 G' Z Y3 J
5 @2 R+ \ |* @* ~; ]# a0 s- a C
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.& V( E+ W9 I2 s! L4 ^+ y+ s m/ Z
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment? D$ B! }4 T! i: F) A5 {. \( u. O
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.6 A) s& `% G. x: R( R* a
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.9 b" G0 J" T. O( q; J8 n+ R, D, {' b
" x+ B* V$ U' PAbstract6 `% \, r8 `; T6 @
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
& |: f T. [( T; |3 o( _( F; s& c, F1 P
( r$ _; _- m$ m! I; _METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
, D' v1 H4 K2 _! }* R5 _/ z8 Q( u5 g( y1 [9 G1 @
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).9 u* y6 R5 e6 w6 V( b2 @; H* j
- b' y8 K) G8 V5 G% b# |
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.4 |( Z2 A' n9 ^" O3 a5 Y' I* h
2 q0 i |% [/ e+ l8 I u. I% K
|
0 _% v1 H7 {/ A3 J3 m& U, `7 r
显身卡
